Correlation of Fc gamma RIIIA receptor expression and response to rituximab and other monoclonal antibodies in patients with Waldenstrom's macroglobulinemia
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Monoclonal antibodies; Rituximab
- Indications Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 27 Jun 2011 Biomarkers information updated
- 22 Jun 2011 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 20 Dec 2007 Status changed from recruiting to discontinued. According to Clinicaltrials.gov this study has been "terminated due to continuing review".